These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8691612)

  • 1. [Molecular microheterogeneity of tumor marker substances and its significance of biological recognition].
    Kuwabara M; Iwakoshi N; Ariyoshi Y
    Nihon Rinsho; 1996 Jun; 54(6):1580-6. PubMed ID: 8691612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
    Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gallbladder carcinoma producing CEA, AFP, CA19-9, sialyl SSEA and CSF].
    Tanigawa N
    Ryoikibetsu Shokogun Shirizu; 1996; (9):237-9. PubMed ID: 8705462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Establishment of reference intervals of tumor markers in Korean adults].
    Woo HY; Kim YJ; Park H
    Korean J Lab Med; 2008 Jun; 28(3):179-84. PubMed ID: 18594168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of several tumor markers in the chest surgery].
    Miyazato I; Tojo N
    Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differences in assay sensitivity of selected tumor markers in head and neck neoplasms].
    Adamiak G; Jurkiewicz D; Polberg K; Konieczna M
    Otolaryngol Pol; 1995; 49 Suppl 20():99-101. PubMed ID: 9454232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of tumour markers in nasopharyngeal carcinoma.
    Kuo WR; Tsai SM; Jong SB; Juan KH
    J Otolaryngol; 1996 Feb; 25(1):32-6. PubMed ID: 8816107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
    Ishii M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G; Müller-Ruchholtz W
    Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor markers for ovarian cancers].
    Aoki D; Kataoka F; Susumu N; Nozawa S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cryptates applied in tumor marker assays (CEA, AFP, CA 15.3, CA19.9): evaluation of Kryptor (Cis-Bio) analyser].
    Gherardi C; Roumier AS; Dubucquoi S; Dessaint JP
    Ann Biol Clin (Paris); 1998; 56(1):92-5. PubMed ID: 9754229
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [National external quality assessment and comparability of assays for tumor markers measurements].
    Zhang JT; Zhang CB; Ma R; Zhao HJ; Wang J; Wang ZG; Chen WX
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):993-7. PubMed ID: 20646652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor markers in the diagnosis of lung cancer].
    Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
    Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
    Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
    J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.